AYTU BIOPHARMA, INC (AYTU) Total liabilities 2016–2025
AYTU BIOPHARMA, INC (AYTU) total liabilities at each fiscal year-end, per SEC filings.
$105.2MFY2025 · since FY2016: $14.3M → $105.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $105.2M | +16.4% |
| FY2024 | $90.4M | -6.9% |
| FY2023 | $97.1M | +4.1% |
| FY2022 | $93.3M | -27.2% |
| FY2021 | $128.1M | +119.8% |
| FY2020 | $58.3M | +110.9% |
| FY2019 | $27.6M | +261.9% |
| FY2018 | $7.6M | -30.6% |
| FY2017 | $11.0M | -22.9% |
| FY2016 | $14.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice